Patents by Inventor Christopher Allen Alvarez-Breckenridge

Christopher Allen Alvarez-Breckenridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210371932
    Abstract: The subject matter disclosed herein is generally directed to detecting and modulating novel gene signatures for the treatment and prognosis of cancer. The gene signatures can be detected in samples obtained from the extracellular fluid of a subject suffering from cancer. The novel gene signatures can be used to predict and monitor responses to immunotherapy in cancer and can be targeted therapeutically. The immunotherapy can be immune checkpoint inhibition therapy.
    Type: Application
    Filed: June 3, 2019
    Publication date: December 2, 2021
    Inventors: Alexander K. Shalek, Sanjay Prakadan, Priscilla K. Brastianos, Christopher Allen Alvarez-Breckenridge, Scott Carter